Mabwell (Shanghai) Bioscience Co., Ltd.

Mabwell (Shanghai) Bioscience Co., Ltd.verified

688062.SS

Price:

$43.05

Market Cap:

$17.20B

Mabwell (Shanghai) Bioscience Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of biological products in China and internationally. The company offers its products for auto-immune, oncology, ophthalmologic, and infectious diseases, as well as metabolic disorders, etc. It offers JUNMAIKANG, an autoimmune Adalimumab injection. The company’s oncology products pipeline includes 9MW2821 and 6MW3211, which are in phase II of clinical trial; 9MW2921, 9MW3811, and 7MW3711, which are in phase I clinical trials; 9MW0321; and 8MW0511, which is in phase III clinical trial. It also develops autoimmune products, such as 9MW1911 and 9MW38...[Read more]

Industry

Biotechnology

IPO Date

2022-01-18

Stock Exchange

SHH

Ticker

688062.SS

The PE Ratio as of December 2025 (TTM) for Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) is -18.16

According to Mabwell (Shanghai) Bioscience Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -18.16. This represents a change of -43.85% compared to the average of -32.34 of the last 4 quarters.

Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) Historical PE Ratio (quarterly & annually)

How has 688062.SS PE Ratio performed in the past?

The mean historical PE Ratio of Mabwell (Shanghai) Bioscience Co., Ltd. over the last ten years is -19.99. The current -18.16 PE Ratio has changed 8.98% with respect to the historical average. Over the past ten years (40 quarters), 688062.SS's PE Ratio was at its highest in in the June 2020 quarter at 0. The PE Ratio was at its lowest in in the September 2025 quarter at -105.84.

Quarterly (TTM)
Annual

Average

-19.99

Median

-12.22

Minimum

-67.81

Maximum

-6.04

Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Mabwell (Shanghai) Bioscience Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 97.42%

Maximum Annual PE Ratio = -6.04

Minimum Annual Increase = -75.05%

Minimum Annual PE Ratio = -67.81

Quarterly (TTM)
Annual
YearPE RatioChange
2024-7.74-34.00%
2023-11.7394.01%
2022-6.04-52.48%
2021-12.72-16.51%
2020-15.2497.42%
2019-7.72-75.05%
2018-30.93-54.39%

Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) Average PE Ratio

How has 688062.SS PE Ratio performed in the past?

The current PE Ratio of Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-8.50

5-year avg

-10.69

10-year avg

-19.99

Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) PE Ratio vs. Peers

How is 688062.SS’s PE Ratio compared to its peers?

Mabwell (Shanghai) Bioscience Co., Ltd.’s PE Ratio is less than Anhui Anke Biotechnology (Group) Co., Ltd. (23.81), less than Inner Mongolia Furui Medical Science Co., Ltd. (149.25), less than DaShenLin Pharmaceutical Group Co., Ltd. (17.74), less than Yunnan Botanee Bio-Technology Group Co.LTD (47.33), greater than Staidson (Beijing) BioPharmaceuticals Co., Ltd. (-79.24), greater than Beijing Hotgen Biotech Co., Ltd. (-59.11), less than Tibet Cheezheng Tibetan Medicine Co., Ltd. (22.62), less than Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (8.95), less than Beijing Aosaikang Pharmaceutical Co., Ltd. (61.78), less than Andon Health Co., Ltd. (8.87),

Build a custom stock screener for Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mabwell (Shanghai) Bioscience Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mabwell (Shanghai) Bioscience Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Mabwell (Shanghai) Bioscience Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS)?

What is the highest PE Ratio for Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS)?

What is the 3-year average PE Ratio for Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS)?

What is the 5-year average PE Ratio for Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS)?

How does the current PE Ratio for Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) compare to its historical average?